Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease.

Graft-versus-host disease (GVHD) is the major complication of allogeneic bone marrow transplantation (BMT). Dysregulation of inflammatory monokines such as tumor necrosis factor alpha (TNF alpha) has been noted in both clinical and experimental GVHD. We present evidence that interleukin-1 (IL-1), another inflammatory monokine, is an important mediator of GVHD. Expression of the gene for IL-1 alpha as well as the gene for TNF alpha is increased in the skin of mice with GVHD. Inhibition of IL-1 function by the in vivo administration of IL-1 receptor antagonist (IL-1ra) reduces the immunosuppression and mortality of GVHD without impairing the engraftment of hematopoietic stem cells. GVHD thus appears to be a systemic inflammatory process in which monokines, especially IL-1, appear to be important mediators. Inhibition of IL-1 by IL-1ra represents a novel approach to the understanding and control of GVHD.

[1]  S. Smith,et al.  A study of cytokine production in acute graft-vs-host disease. , 1991, Cellular immunology.

[2]  K. McIntyre,et al.  Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody , 1991, The Journal of experimental medicine.

[3]  K. Atkinson,et al.  In vivo administration of granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage CSF, interleukin-1 (IL-1), and IL-4, alone and in combination, after allogeneic murine hematopoietic stem cell transplantation. , 1991, Blood.

[4]  R. Cotran,et al.  The role of endothelial cells in inflammation. , 1990, Transplantation.

[5]  H. Ford,et al.  Tumor necrosis factor, macrophage colony-stimulating factor, and interleukin 1 production within sponge matrix allografts. , 1990, Transplantation.

[6]  M. Pepe,et al.  Serum tumor necrosis factor alpha associated with acute graft-versus-host disease in humans. , 1990, Transplantation.

[7]  R. Champlin.  T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation. , 1990, Hematology/oncology clinics of North America.

[8]  W. Lehmacher,et al.  Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. , 1990, Blood.

[9]  M. T. Brewer,et al.  Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist , 1990, Nature.

[10]  Robert C. Thompson,et al.  Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor , 1990, Nature.

[11]  Lesley J. Murray,et al.  In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp‐lpr/lpr mouse , 1990, European journal of immunology.

[12]  W. Lehmacher,et al.  Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. , 1990, Blood.

[13]  D. Longo,et al.  Interleukin-1 enhances survival of lethally irradiated mice treated with allogeneic bone marrow cells. , 1989, Blood.

[14]  T. Ikejima,et al.  Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. , 1988, The Journal of clinical investigation.

[15]  C. Dinarello,et al.  Biology of interleukin 1 , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  P. Vassalli,et al.  Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease , 1987, The Journal of experimental medicine.

[17]  B. Mach,et al.  A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alpha. , 1987, Journal of immunology.

[18]  R. Miller,et al.  Functional T cell deficits after bone marrow transplantation across minor histocompatibility barriers: effects of graft-vs-host disease on precursor frequency of reactive cells. , 1987, Journal of immunology.

[19]  J. Vilček,et al.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[20]  T. Ghayur,et al.  The Functional and Histological Basis for Graft‐versus‐Host‐Induced Immunosuppression , 1985, Immunological reviews.

[21]  W. J. Cromartie,et al.  Reactivation of streptococcal cell wall-induced arthritis by homologous and heterologous cell wall polymers. , 1985, Arthritis and rheumatism.

[22]  J. Sprent,et al.  Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow , 1978, The Journal of experimental medicine.

[23]  F. Sieber,et al.  Erythroid progenitors in mouse bone marrow detected by macroscopic colony formation in culture. , 1975, Experimental hematology.

[24]  J. Till,et al.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. , 1961, Radiation research.